Saliva resistin as a screening marker of gestational diabetes mellitus.
Beril GurlekSabri ÇolakPublished in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2020)
The results indicate that the determination of saliva resistin levels at the gestational age between 24 to 28 weeks may be used as an alternative, stress-free, and noninvasive technique that may be used in GDM screening.